A5030062016- Thyroid Cancer Diagnosis and Treatment
- Thyroid and Parathyroid Surgery
- COVID-19 and healthcare impacts
- Pancreatic and Hepatic Oncology Research
- Healthcare cost, quality, practices
- Cardiac, Anesthesia and Surgical Outcomes
- Neuroendocrine Tumor Research Advances
- Parathyroid Disorders and Treatments
- Radiation Dose and Imaging
- Intraperitoneal and Appendiceal Malignancies
- Ovarian cancer diagnosis and treatment
- BRCA gene mutations in cancer
- Pituitary Gland Disorders and Treatments
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Biomarkers in Disease Mechanisms
- Hepatocellular Carcinoma Treatment and Prognosis
- Salivary Gland Tumors Diagnosis and Treatment
- Esophageal Cancer Research and Treatment
- Enhanced Recovery After Surgery
- Patient-Provider Communication in Healthcare
- Medical Imaging and Pathology Studies
- Hormonal Regulation and Hypertension
- Appendicitis Diagnosis and Management
- Adrenal and Paraganglionic Tumors
- Lung Cancer Diagnosis and Treatment
Rutgers Cancer Institute of New Jersey
2021-2024
Rutgers, The State University of New Jersey
2020-2024
Johnson University
2021-2024
Rutgers Health
2023-2024
Twitter (United States)
2024
Penn State Milton S. Hershey Medical Center
2024
Pennsylvania State University
2024
American Association of Neurological Surgeons
2023
Rutgers Sexual and Reproductive Health and Rights
2023
American College of Surgeons
2022
Abstract Background Mucinous appendiceal adenocarcinomas (MAA) and non-mucinous (NMAA) demonstrate differences in rates patterns of recurrence, which may inform the appropriate extent surgical resection (i.e., appendectomy versus colectomy). The impact on disease-specific survival (DSS) for each histologic subtype was assessed. Patients Methods with resected, non-metastatic MAA NMAA were identified Surveillance, Epidemiology, End Results database (2000–2020). Multivariable models created to...
The 2015 American Thyroid Association (ATA) guidelines recommended thyroid lobectomy (TL) as an alternative to total thyroidectomy (TT) for the surgical treatment of low-risk differentiated cancer. Increasing use TL has since been reported despite concerns increased risk disease recurrence and need reoperation. This study sought compare reoperation rates among patients who underwent initial or TT malignancy, characterize trends at centers based on operative volume, examine factors associated with
Introduction: Pediatric papillary thyroid carcinomas (PTCs) are more invasive than adult PTCs. No large, contemporary cohort study has been conducted to determine whether younger children at higher risk for advanced disease presentation compared adolescents. We aimed describe pediatric PTC and contextualize its characteristics with a young comparison cohort. Methods: The National Cancer Database was interrogated PTCs diagnosed between 2004 2017. Clinical variables were prepubertal (≤10 years...
Introduction: Malignant struma ovarii (MSO) is a rare thyroid cancer arising within an ovarian teratoma. While surgical excision of the primary tumor widely accepted as standard care, recommendations for adjuvant treatment MSO-whether or not to administer radioactive iodine (RAI)-are based largely on case reports and remain debated. In this study, we aimed propose risk stratification analyze RAI utilization patterns in MSO cases. Methods: The National Cancer Database (NCDB) was queried...
The significance of low mitotic activity in papillary thyroid cancer (PTC) is largely undefined.
In this SEER-database analysis (https:/
BackgroundRacial and ethnic disparities have been observed in the multidisciplinary management of pancreatic ductal adenocarcinoma. Intraductal papillary mucinous neoplasm is most common identifiable precursor to adenocarcinoma, where early surgical intervention before development an invasive intraductal improves survival. The association race/ethnicity with risk identifying neoplasms during resection has not previously defined.MethodsThe American College Surgeons National Quality...